News & announcements

Stemedix

Official newsroom
← Back to newsroom

Stemedix Shares Patient Guides on Chronic Pain Care

Stemedix 6 v2.jpg

Saint Petersburg, Florida, September 15, 2026 – Stemedix has published new educational blogs that provide practical information about regenerative pain management, including the chronic pain conditions it may address and what patients can expect during the evaluation process before treatment begins. The publications are intended to help individuals better understand how physicians assess chronic pain and develop personalized treatment recommendations based on each patient's diagnosis and medical history.

As more people seek information about long-term pain management, the new educational content offers a closer look at the clinical process used to evaluate chronic pain conditions and the factors that guide treatment planning for patients exploring pain management in Saint Petersburg, FL.

Regenerative Pain Management Begins With Identifying the Source of Pain

Chronic pain is not caused by a single condition, and patients with similar symptoms may have different underlying medical issues. Joint degeneration, degenerative disc disease, autoimmune-related joint pain, fibromyalgia-associated inflammation, and neuropathic pain can all contribute to long-term discomfort, but each condition may require a different clinical approach.

Rather than focusing only on reducing pain symptoms, regenerative pain management starts with identifying the underlying cause of the condition. Physicians evaluate medical history, diagnostic imaging, laboratory findings, and previous diagnoses before determining which regenerative therapies may be appropriate for each individual.

Depending on the patient's condition, treatment options may include:

  • Platelet-rich plasma (PRP) therapy

  • Regenerative joint injections

  • Prolozone therapy

  • Ozone IV therapy

  • Targeted regenerative injections for nerve-related pain

This personalized approach recognizes that treatment decisions should reflect the patient's condition rather than follow the same pathway for everyone experiencing chronic pain.

Clinical Research Continues to Support Personalized Care

Published research continues to expand knowledge about regenerative therapies used for chronic musculoskeletal conditions.

A retrospective study published by the National Institutes of Health (NIH) found that 70.6% of patients with knee osteoarthritis met treatment response criteria 12 months after completing a series of platelet-rich plasma (PRP) injections. Individual outcomes may differ depending on the patient's diagnosis, severity of disease, and overall health.

Findings such as these continue to contribute to discussions about individualized treatment planning and the role regenerative medicine may play in managing chronic pain.

Pain Management Visits Focus on Thorough Patient Evaluation

Developing a personalized treatment plan begins with gathering complete and current medical information. Physicians typically review existing diagnoses, recent blood work, MRI findings, imaging studies, and other relevant medical records before making treatment recommendations.

If records are no longer current, updated documentation may be requested so that treatment decisions reflect the patient's present condition.

Follow-up appointments also remain an important part of the care process. These visits allow physicians to monitor pain levels, physical function, medication changes, and clinical progress while making adjustments when appropriate.

"Patients often have questions about why evaluations involve more than a single office visit," said Fred Palmer, CEO of Stemedix. "Reviewing a patient's diagnosis, medical history, and clinical records allows physicians to better understand the condition before discussing regenerative treatment options. Providing educational information helps patients know what to expect throughout that process."

Pain Management Continues to Be a National Healthcare Priority

The need for reliable information about pain management continues to grow as chronic pain affects millions of adults across the country.

According to the Centers for Disease Control and Prevention (CDC), 24.3% of U.S. adults experienced chronic pain in 2023. The prevalence of chronic pain has increased interest in treatment approaches that evaluate each patient's condition individually rather than relying solely on symptom-based care.

For people researching pain management in Saint Petersburg, FL, understanding how physicians evaluate chronic pain can provide valuable context before scheduling an appointment. Reviewing medical records, confirming diagnoses, and monitoring patient progress over time all contribute to a structured clinical process that supports individualized care.

As interest in regenerative pain management continues to grow, access to educational information can help patients better understand the evaluation process and the factors physicians consider when developing treatment recommendations.

About Stemedix

Stemedix is a regenerative medicine provider based in Saint Petersburg, Florida, offering personalized care for individuals living with chronic pain and other complex medical conditions. The organization focuses on evaluating each patient's diagnosis, medical history, laboratory findings, and imaging before physicians develop individualized treatment recommendations. 

Media Contact

Fred Palmer

CEO, Stemedix

Bayfront Medical Plaza 601

7th Street S. Suite 565

Florida, Saint Petersburg 33701

Phone: (727) 456-8968

Email: yourjourney@stemedix.com

Contact Page: https://stemedix.com/contact/

Stemedix 6 v2.jpgStemedix 5 v2.jpg

Source: https://stemedix.mediaroom.press/news/stemedix-shares-patient-guides-on-chronic-pain-care-kVGot4